Last reviewed · How we verify
gatifloxacin and moxifloxacin — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
gatifloxacin and moxifloxacin (gatifloxacin and moxifloxacin) — Donnenfeld, Eric, M.D..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| gatifloxacin and moxifloxacin TARGET | gatifloxacin and moxifloxacin | Donnenfeld, Eric, M.D. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- gatifloxacin and moxifloxacin CI watch — RSS
- gatifloxacin and moxifloxacin CI watch — Atom
- gatifloxacin and moxifloxacin CI watch — JSON
- gatifloxacin and moxifloxacin alone — RSS
Cite this brief
Drug Landscape (2026). gatifloxacin and moxifloxacin — Competitive Intelligence Brief. https://druglandscape.com/ci/gatifloxacin-and-moxifloxacin. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab